本发明提供的是一种左旋多巴(L - DOPA)改性有机-无机复合药物缓释支架涂层的制备方法。
The invention relates to a preparation method of an L-DOPA (levodopa) modified organic-inorganic composite medicine slow release stent coating.
分析人士估计如果Xience能够顺利上市，它将在未来几年里获得药物涂层支架市场45%的份额，美国药物涂层支架市场每年的总量大概是18亿美元。
The analysts estimate that Xience could gain as much as 45 percent of a $1.8 billion American annual market for drug-coated stents over the next few years.
应用推荐